Haemonetics (HAE) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Haemonetics names Anila Lingamneni as EVP, Chief Technology Officer HAE
Brokerages predict that Haemonetics Co. (NYSE:HAE) will announce sales of $246.31 million for the current quarter, Zacks reports. Three analysts have issued estimates for Haemonetics’ earnings, with
AQR Capital Management LLC decreased its holdings in shares of Haemonetics Co. (NYSE:HAE) by 49.3% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Comm
Co-Diagnostics (NASDAQ:CODX) and Haemonetics (NYSE:HAE) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, pro
Morgan Stanley analyst David Lewis maintained a Buy rating on Haemonetics (HAE) today and set a price target of $138.00. The company's shares closed last
Morgan Stanley analyst David Lewis maintained a Buy rating on Haemonetics ( HAE – Research Report ) today and set a price target of $138.00 . The company’s shares closed last Monday at $102.99. Ac
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was
Amundi Pioneer Asset Management Inc. raised its position in shares of Haemonetics Co. (NYSE:HAE) by 38.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Ex

Haemonetics (NYSE:HAE) Stock Price Up 2.2%

06:22am, Friday, 27'th Mar 2020
Haemonetics Co. (NYSE:HAE)’s stock price rose 2.2% during mid-day trading on Wednesday . The stock traded as high as $95.77 and last traded at $97.62, approximately 29,335 shares were traded during
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P; 500 Index wa
Coronavirus is probably the 1 concern in investors' minds right now. It should be. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW. We predicted
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE